Janus Henderson Group PLC Avidity Biosciences, Inc. Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 11,426,696 shares of RNA stock, worth $353 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
11,426,696
Previous 7,053,010
62.01%
Holding current value
$353 Million
Previous $205 Million
64.46%
% of portfolio
0.19%
Previous 0.11%
Shares
12 transactions
Others Institutions Holding RNA
# of Institutions
244Shares Held
116MCall Options Held
289KPut Options Held
998K-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$350 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$299 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$286 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$270 Million4.23% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$266 Million0.01% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.61B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...